pyrroles has been researched along with Arteriovenous Malformations in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bédouet, L; Jubeli, E; Labarre, D; Laurent, A; Moine, L; Pascale, F; Saint-Maurice, JP; Slimani, K; Yagoubi, N | 1 |
1 other study(ies) available for pyrroles and Arteriovenous Malformations
| Article | Year |
|---|---|
Embolization biomaterial reinforced with nanotechnology for an in-situ release of anti-angiogenic agent in the treatment of hyper-vascularized tumors and arteriovenous malformations.
Topics: Acrylates; Angiogenesis Inhibitors; Animals; Arteriovenous Malformations; Biocompatible Materials; Cell Proliferation; Cells, Cultured; Cornea; Delayed-Action Preparations; Drug Compounding; Drug Delivery Systems; Embolization, Therapeutic; Endothelium, Vascular; Gels; Human Umbilical Vein Endothelial Cells; Indoles; Intercostal Muscles; Nanospheres; Neovascularization, Pathologic; Pyrroles; Rabbits; Random Allocation; Sheep, Domestic; Sunitinib | 2015 |